EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:233445 - (±)-suloctidil
| ChEBI ID | CHEBI:233445 |
| ChEBI Name | (±)-suloctidil |
| Stars | |
| ASCII Name | (+-)-suloctidil |
| Definition | A racemate comprising equimolar amounts of the erythro isomers, (1R,2S)-suloctidil and (1S,2R)-suloctidil. |
| Last Modified | 5 February 2025 |
| Submitter | Adnan |
| Formula | C20H35NOS |
| Net Charge | 0 |
| Average Mass | 337.573 |
| Monoisotopic Mass | 337.24394 |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | antifungal agent An antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce. calcium channel blocker One of a class of drugs that acts by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools. hepatotoxic agent A role played by a chemical compound exhibiting itself through the ability to induce damage to the liver in animals. |
| Applications: | cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. vasodilator agent A drug used to cause dilation of the blood vessels. platelet aggregation inhibitor A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| (±)-suloctidil (CHEBI:233445) has part (1R,2S)-suloctidil (CHEBI:233451) |
| (±)-suloctidil (CHEBI:233445) has part (1S,2R)-suloctidil (CHEBI:233450) |
| (±)-suloctidil (CHEBI:233445) has role antifungal agent (CHEBI:35718) |
| (±)-suloctidil (CHEBI:233445) has role calcium channel blocker (CHEBI:38215) |
| (±)-suloctidil (CHEBI:233445) has role cardiovascular drug (CHEBI:35554) |
| (±)-suloctidil (CHEBI:233445) has role hepatotoxic agent (CHEBI:50908) |
| (±)-suloctidil (CHEBI:233445) has role platelet aggregation inhibitor (CHEBI:50427) |
| (±)-suloctidil (CHEBI:233445) has role vasodilator agent (CHEBI:35620) |
| (±)-suloctidil (CHEBI:233445) is a racemate (CHEBI:60911) |
| IUPAC Name |
|---|
| rac-(1R,2S)-2-(octylamino)-1-[4-(propan-2-ylsulfanyl)phenyl]propan-1-ol |
| INNs | Source |
|---|---|
| suloctidil | WHO MedNet |
| suloctidil | WHO MedNet |
| suloctidil | WHO MedNet |
| suloctidilum | WHO MedNet |
| Synonyms | Source |
|---|---|
| CP 556 S | ChEBI |
| CP556S | ChEBI |
| CP-556S | ChEBI |
| MJF-12637 | ChEBI |
| erythro-p-(isopropylthio)-α-[1-(octylamino)ethyl]benzyl alcohol | ChEBI |
| CP 556S | ChEBI |
| Brand Names | Source |
|---|---|
| Fluvisco | ChEBI |
| Cerebro | ChEBI |
| Loctidon | ChEBI |
| Bemperil | ChEBI |
| Euvasal | ChEBI |
| Fluversin | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| Suloctidil | Wikipedia |
| DB13340 | DrugBank |
| HMDB0242578 | HMDB |
| D05967 | KEGG DRUG |
| 2536 | DrugCentral |
| LSM-1469 | LINCS |
| GB2123291 | Patent |
| Registry Numbers | Sources |
|---|---|
| CAS:54767-75-8 | ChEBI |
| Citations |
|---|